دورية أكاديمية

High-dose-rate brachytherapy for soft tissue sarcoma in children: a single institution experience.

التفاصيل البيبلوغرافية
العنوان: High-dose-rate brachytherapy for soft tissue sarcoma in children: a single institution experience.
المؤلفون: Viani GA, Novaes PE, Jacinto AA, Antonelli CB, Pellizzon AC, Saito EY, Salvajoli JV, Viani, Gustavo A, Novaes, Paulo E, Jacinto, Alexandre A, Antonelli, Celia B, Pellizzon, Antonio Cassio A, Saito, Elisa Y, Salvajoli, João V
المصدر: Radiation Oncology; 2008, Vol. 3, p9-9, 1p
مستخلص: Purpose: To report our experience treating soft tissue sarcoma (STS) with high dose rate brachytherapy alone (HBRT) or in combination with external beam radiotherapy (EBRT) in pediatric patients.Methods and Materials: Eighteen patients, median age 11 years (range 2 - 16 years) with grade 2-3 STS were treated with HBRT using Ir-192 in a interstitial (n = 14) or intracavitary implant (n = 4). Eight patients were treated with HBRT alone; the remaining 10 were treated with a combination of HBRT and EBRT.Results: After a median follow-up of 79.5 months (range 12 - 159), 14 patients were alive and without evidence of disease (5-year overall survival rate 84.5%). There were no local or regional failures in the group treated with HBRT alone. One patient developed distant metastases at 14 months and expired after 17 months. In the combined HBRT and EBRT group, there was 1 local failure (22 months), and 3 patients developed pulmonary metastatic disease 18, 38 and 48 months after diagnosis and no these patients were alive at the time of this report. The overall local control to HBRT alone and HBRT plus EBRT were 100 and 90%, respectively. The acute affects most common were local erythema and wound dehiscence in 6 (33%) and 4 (22%) patients. Late effects were observed in 3 patients (16.5%).Conclusion: Excellent local control with tolerable side effects have been observed in a small group of paediatric patients with STS treated by HBRT alone or in combination with EBRT. [ABSTRACT FROM AUTHOR]
Copyright of Radiation Oncology is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index